Pfizer Statement on the Life Sciences Blueprint

September 10th, 2009 LONDON - The Association of British Pharmaceutical Industry (ABPI) will be launching their manifesto 'Prescription for Innovation' on Monday 14 September at Imperial College. The manifesto will be launched by Chris Brinsmead, President of the ABPI, in partnership with Richard Lambert of the CBI, Professor Steve Smith of Imperial and Ade Adeagbo of patients' organisation National Voices.

September 7th, 2009 FRANKFURT - LORENZ Life Sciences Group // Frankfurt, Germany // LORENZ Life Sciences Group, the largest supplier of eCTDs in the world, announced the final release of the userBridge.09 agenda, LORENZ' well established user conference. The conference will be held in Warsaw, Poland and will take place on 22 - 24 September 2009.

August 10th, 2009 LONDON - Ex-smokers across the UK still have time to enter stop smoking charity QUIT's competition to find the country's most inspirational quitters and win the holiday of a lifetime. QUIT(R), along with the European Network of Quitlines, is inviting smokers who have kicked the habit to enter the European Smoke Free Awards 2009, with a grand prize of EUR5,000 (GBP4,250) in holiday vouchers for the overall winner.

May 12th, 2009 NERVIANO, Italy - The FDA has approved an Investigational New Drug (IND) application by Nerviano Medical Sciences to begin a phase I clinical study with its selective PLK-1 small molecule inhibitor for the treatment of cancer. PLK-1 is a mitotic kinase required for the proliferation of cancer cells.

April 22nd, 2009 FRANKFURT AM MAIN, Germany - LORENZ today announced the release of version 3.0 of its popular eValidator validation tool. The name change from eCTD Validator reflects the broader validation scope the tool has received in this major upgrade.

April 21st, 2009 LONDON - The UK Advertising Standards Authority (ASA) today ruled that Pfizer's groundbreaking cinema advertising in which a man is seen coughing-up a dead rat did not breach the industry advertising code.(1) The advert, seen by cinema audiences across the UK, highlights the danger of obtaining medicines from unregulated sources (see www.realdanger.co.uk). Evidence shows there is a risk of these medicines being counterfeit, containing too little, too much or no active ingredient, or worse, toxic substances such as rat poison, boric acid or lead paint.(4) The ASA investigated the advert having received 63 complaints from members of the public.

April 15th, 2009 LONDON - Pharmaceutical companies GlaxoSmithKline and Pfizer today announced an "innovative agreement" to pool their HIV assets creating a new world-leading, specialist HIV company. The deal will see the drug giants combine their existing HIV product and their pipelines with GSK holding 85% of the company and Pfizer 15%.

April 8th, 2009 KREMS, Austria - The IMC University of Applied Sciences Krems is being awarded the tender for the structural and academic development of the University of Buraimi, Oman. Therewith, one of Austria's most international Universities of Applied Sciences has been able to assert itself against five international competitors.

April 8th, 2009 PETALUMA, California - Featuring US experts in topical dermatological drug development Dow Pharmaceutical Sciences, Inc. today announced that it will hold a 1-day workshop on "Topical Dermatological Product Development in the USA" June 4, 2009 at the Hilton East Brunswick, New Jersey.

March 30th, 2009 PARIS - OFCE Economic Research Centre Sciences PO Paris - G20, and After... - Revival - Regulation - Reform United Nations, Interactive Thematic Dialogue with the General Assembly, 25-27 March 2009 (www.un.org/ga/president/63/interactive/worldfinancialcrisis.shtml) Recommendations by the Commission of Experts, Joseph Stiglitz (Prize Nobel winner), President of the commission, Research fellow at OFCE, Jean-Paul Fitoussi (www.ofce.sciences-po.fr/fitoussi/accueil_fitou.html), President of the Sub-commission, "Macro-issues and perspectives".

April 13th, 2009 MUMBAI - Global pharmaceutical major Pfizer Monday said it will make an offer to acquire a further 33.77 percent in its Indian subsidiary Pfizer Ltd for Rs.6.8 billion. The acquisition will raise its stake to 75 percent.

September 30th, 2009 Pfizer, Wyeth deal gets clearance in ChinaNEW YORK — Drug developer Pfizer Inc. said Tuesday China's ministry of commerce approved the company's $68 billion buyout of rival Wyeth.

July 7th, 2009 Pfizer ends plan San Francisco biotech facilityNEW YORK — Pfizer Inc. is pulling a plan to staff a biotechnology research center in San Francisco and will keep its 100 area employees in South San Francisco.

April 13th, 2009 MUMBAI - Pfizer Investments Netherlands B.V., an indirect wholly-owned subsidiary of Pfizer Inc, today announced that it will make a tender offer to acquire a 33.77 per cent stake in Pfizer Limited from public shareholders at a price of Rs. 675.00 per share.

September 30th, 2009 Pfizer, Wyeth deal gets clearance in AustraliaNEW YORK — Drug developer Pfizer says the Australian Competition and Consumer Commission approved the company's $68 billion buyout of rival Wyeth. Pfizer will divest certain animal health assets in Australia, the New York-based company says.

July 15th, 2009 BANGALORE - Nobel laureate Amartya Sen will chair a five-member jury of the Infosys Science Foundation, set up by IT bellwether Infosys Technologies Ltd, to select winners for its awards in five science disciplines, the company said Wednesday. Sen will chair the jury for social sciences.

June 19th, 2009 NEW DELHI - Delhi Friday became the first state to compile and release a blueprint on implementation of the National Knowledge Commission's recommendations for educational reforms. "The Delhi government has taken the lead in compiling a blueprint on implementation of NKC recommendations and is the first state to release the blueprint," said commission chairman Sam Pitroda, while releasing the document at the Delhi legislative assembly.

September 2nd, 2009 Pfizer to pay record $2.3 billion settlementWASHINGTON — People familiar with a record legal settlement to be announced Wednesday say that Pfizer Inc., the world's largest drugmaker, will pay $2.3 billion in connection with illegal drug promotions. The U.S. Justice Department plans a news conference later in the day to announce the terms of the deal.

February 13th, 2009 THIRUVANANTHAPURAM - State-run Kerala State Industrial Development Corp (KSIDC) will set up a state-of-the-art life science park near here, it was announced Saturday. The Rs.3 billion (Rs.300 crore) project would be developed under public-private partnership model, a KSIDC release said.

June 18th, 2009 Wyeth sets meeting for shareholders' merger voteMORRISTOWN, N.J. — Wyeth has scheduled a meeting for the drugmaker's shareholders to vote whether to approve its pending acquisition by drug giant Pfizer.